Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LeukoSep System with SOLX Additive Pivotal Trial
NCT02145507Phase 1Completed
- Sponsor
- Haemonetics
- Start
- Apr 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised trial of SOLX in anemia and hemorrhage (2 arms), sponsored by Haemonetics. Primary endpoints: Red Blood Cell Post-filtration Recovery and Residual Leukocyte Count. Started Apr 2014; status: completed.
02
Drugs
SOLX
03
Conditions
anemiahemorrhage
Beyond the preview
Go deeper on NCT02145507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145507.